PARMODIA

Serial Number 79370102
Registration 7296358
700

Registration Progress

Application Filed
Feb 17, 2023
Under Examination
Approved for Publication
Nov 21, 2023
Published for Opposition
Nov 21, 2023
Registered
Feb 6, 2024

Trademark Image

PARMODIA

Basic Information

Serial Number
79370102
Registration Number
7296358
Filing Date
February 17, 2023
Registration Date
February 6, 2024
Published for Opposition
November 21, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 6, 2024
Registration
Registered
Classes
005

Rights Holder

KOWA COMPANY, LTD.

03
Address
6-29, Nishiki 3-chome,
Naka-ku, Nagoya-shi, Aichi-ken 460-8625
JP

Ownership History

KOWA COMPANY, LTD.

Original Applicant
03
JP

KOWA COMPANY, LTD.

Owner at Publication
03
JP

KOWA COMPANY, LTD.

Original Registrant
03
JP

Legal Representation

Attorney
Erica Halstead

USPTO Deadlines

Next Deadline
1652 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-02-06)
Due Date
February 06, 2030
Grace Period Ends
August 06, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Jun 17, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
May 13, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 13, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 6, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 6, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 6, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 27, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Nov 21, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 21, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 1, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Nov 1, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Nov 1, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 13, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 3, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 3, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 2, 2023 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Aug 14, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 24, 2023 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Jul 24, 2023 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Loading...
Jul 14, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jul 14, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 12, 2023 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Jun 8, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 25, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 23, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 19, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 18, 2023 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain

Classification

International Classes
005